FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
NFE2L2 |
NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 |
39.130 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
ACP1 |
ACP1: Low molecular weight phosphotyrosine protein phosphatase |
39.130 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
39.130 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
39.130 |
Evidence |
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
NFE2L2 |
NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 |
39.130 |
Evidence |
|
FGA |
IPI00021885 |
LPA |
LPA: Apolipoprotein(a) precursor |
39.130 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
39.130 |
Evidence |
|
ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
39.130 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
39.130 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
39.130 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
39.130 |
Evidence |
|
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
PKMYT1 |
PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito |
39.130 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
39.130 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
SH3BP5 |
IPI00006776 |
39.130 |
Evidence |
|
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
39.130 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
SH3BP5 |
IPI00006776 |
39.130 |
Evidence |
|
THBD |
THBD, THRM: Thrombomodulin precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
39.030 |
Evidence |
|
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
39.010 |
Evidence |
|
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
39.010 |
Evidence |
|
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
39.010 |
Evidence |
|
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
39.010 |
Evidence |
O
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GAD2 |
GAD2, GAD65: Glutamate decarboxylase 2 |
39.010 |
Evidence |
|
ADPRT |
PARP1, ADPRT, PPOL: Poly [ADP-ribose] polymerase 1 |
HMGB2 |
HMGB2, HMG2: High mobility group protein B2 |
38.750 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
EP300 |
IPI00478752 |
38.750 |
Evidence |
|
HNRPK |
IPI00216746 |
SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
38.550 |
Evidence |
|